Savara director exercises options for 1,807 shares

Savara Inc director Joseph S. McCracken exercised stock options on February 16, 2026 to acquire 1,807 shares of common stock at $1.76 per share.

Rhea-AI Filing Summary

Savara Inc director Joseph S. McCracken exercised stock options on February 16, 2026 to acquire 1,807 shares of common stock at $1.76 per share. These options, granted at an exercise price of $1.76, had vested in twelve equal quarterly installments beginning on March 15, 2017. After this option exercise, McCracken directly holds 302,644 shares of Savara common stock.

Insider Trade Summary

1,807 shares exercised/converted

Exercise 2 txns

Insider McCracken Joseph S

Role Director

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to buy)	1,807	$0.00	$0.00
Exercise	Common Stock	1,807	$1.76	$3K

Holdings After Transaction: Stock Option (right to buy) — 0 contracts (Direct); Common Stock — 302,644 shares (Direct)

Footnotes (1)

1. F1. The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 15, 2017.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Savara Inc (SVRA) disclose for Joseph S. McCracken?

Savara Inc reported that director Joseph S. McCracken exercised stock options to acquire 1,807 shares of common stock at $1.76 per share. This option exercise converted derivative securities into common stock and increased his directly held Savara share balance.

How many Savara (SVRA) shares does Joseph S. McCracken own after this Form 4 transaction?

After the reported transaction, Joseph S. McCracken directly owns 302,644 shares of Savara common stock. This figure reflects his holdings following the exercise of options for 1,807 shares on February 16, 2026, as shown in the Form 4.

What was the exercise price for the Savara (SVRA) stock options exercised by Joseph S. McCracken?

The exercised Savara stock options had an exercise price of $1.76 per share. On February 16, 2026, McCracken converted 1,807 option rights into an equal number of common shares at this fixed exercise price, as reported in the Form 4.

When did Joseph S. McCracken’s Savara (SVRA) stock options begin vesting?

The stock options began vesting on March 15, 2017. According to the footnote, the option vested and became exercisable in twelve equal quarterly installments starting on that date, leading up to the full exercisability prior to the February 2026 exercise.

What type of derivative security did Joseph S. McCracken exercise in the Savara (SVRA) Form 4?

He exercised a stock option, described as a “Stock Option (right to buy).” This derivative security entitled him to purchase 1,807 Savara common shares at $1.76, and after exercise, the remaining number of these derivative securities reported is zero.

Is Joseph S. McCracken a director or officer of Savara Inc (SVRA)?

Joseph S. McCracken is identified as a director of Savara Inc in the filing. The Form 4 indicates he is not listed as an officer or 10% owner, confirming his role specifically as a board member involved in this option exercise.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 05:30 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McCracken Joseph S

(Last) (First) (Middle)

ONE SUMMIT SQUARE,

1717 LANGHORNE NEWTOWN ROAD, SUITE 300

(Street)

LANGHORNE PA 19047

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Savara Inc [ SVRA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/16/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/16/2026	02/16/2026	M		1,807	A	$1.76	302,644	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$1.76	02/16/2026	02/16/2026	M			1,807	(1)	12/15/2026	Common Stock	1,807	$0.00	0	D

Explanation of Responses:

1. The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 15, 2017.

	/s/ David Lowrance as attorney-in-fact for Joseph S. McCracken	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.